Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Gastroenterology

Why Are Antidepressants Prescribed for IBS Symptoms?

At a Glance

For IBS, some antidepressants are used in low doses to change how the brain and gut process pain—not because symptoms are psychological. Tricyclics may help abdominal pain and diarrhea-predominant IBS, while SSRIs are not routine IBS treatment.

When your doctor prescribes an antidepressant for Irritable Bowel Syndrome (IBS), they are usually not treating clinical depression or suggesting that your physical pain is “all in your head” [1][2]. Instead, gastroenterologists often use these medications in much lower doses as neuromodulators (medicines that change nerve signaling) [1]. Their goal is to treat visceral hypersensitivity—an increased sensitivity to signals from the digestive organs—by altering how the brain and gut communicate, dampening pain signals, and regulating how fast food moves through your digestive tract [1][3][4]. These medications are typically considered after or alongside foundational measures like diet changes, lifestyle adjustments, and standard symptom treatments.

The Gut-Brain Axis and Visceral Hypersensitivity

Your brain and digestive system are in constant communication through a network of nerves known as the gut-brain axis [3]. In people with IBS, this communication network is often dysregulated, leading to visceral hypersensitivity [1][3]. This means that ordinary gut sensations—like normal digestion or small amounts of gas—are amplified and perceived by the brain as severe pain [3].

The chemical messengers (neurotransmitters) that regulate mood in the brain, such as serotonin and noradrenaline, are also part of the overlapping signaling systems that regulate pain, sensation, and the speed of bowel movement (motility) in the gut [4][5]. Because the brain and gut use these shared messengers, medications designed to adjust them can help modulate gut-brain pain processing and sensitivity [4].

Low Doses for Pain Relief

When treating IBS, doctors typically prescribe these medications at much lower doses than they would to treat a psychiatric condition [6]. For example, low-dose tricyclic antidepressants (TCAs) might be started at a low dose like 10 mg a day for IBS [7].

Research shows that these targeted doses can reduce abdominal pain and improve overall IBS symptoms without changing a patient’s anxiety or depression scores [7][6]. This suggests that the benefit is not explained solely by improved mood, but rather by altering central pain processing [1]. Because of this, specialists refer to them as “central neuromodulators” when used for IBS [1].

Matching the Medication to Your IBS Type

Doctors consider specific types of neuromodulators based on your primary bowel symptoms and other health conditions [4]:

  • Tricyclic Antidepressants (TCAs): Medications like amitriptyline are recommended by some guidelines for overall IBS symptoms and pain [8][9]. Because they tend to slow down digestion, they are especially helpful for patients with diarrhea-predominant IBS (IBS-D) [4][10]. However, because they can cause constipation, they must be used carefully in those who already struggle with regular bowel movements [11].
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Major guidelines do not recommend SSRIs as a standard treatment for IBS [12][9]. The evidence supporting their benefit for IBS pain is limited and inconsistent [12][13]. Although they can alter gut motility and cause diarrhea, they are typically only considered when a patient has a coexisting condition like depression or anxiety [4][12].

What to Expect and Medication Safety

It takes time for neuromodulators to alter nerve pathways. Relief from IBS pain may take 4 to 8 weeks to become noticeable, and successful treatment might be continued for 6 to 12 months, depending on your response [4].

Potential Side Effects and Risks:
Even at low doses, side effects can happen.

  • TCAs can cause anticholinergic effects like dry mouth, blurred vision, difficulty urinating, and constipation [14][4]. They also carry potential cardiac risks, such as a fast or irregular heartbeat, changes in electrical conduction (QT interval), and dizziness from low blood pressure [14][4].
  • SSRIs can cause nausea, diarrhea, sexual side effects, and changes in sleep [12][4].

Important Safety Warnings:

  • Do not start, increase, combine, or stop these medicines without your prescriber. Tapering must be individualized by your doctor so you can avoid discontinuation symptoms (effects that can occur after stopping a medicine abruptly) [4].
  • Contact your clinician promptly if you experience major mood or behavior changes, severe agitation, suicidal thoughts, severe allergic reactions, or fainting [14][6].
  • Be sure to review all prescriptions, over-the-counter medications, and supplements with your doctor to avoid dangerous drug interactions [11].

When It Might Not Be IBS:
Always seek a medical evaluation if you have “alarm symptoms” such as rectal bleeding, unexplained weight loss, persistent vomiting, symptoms that regularly wake you up at night, anemia, or a strong family history of colon cancer or inflammatory bowel disease. These are not typical of IBS and require separate investigation.

Common questions in this guide

Why would an antidepressant be prescribed for IBS if I am not depressed?
Some antidepressants affect the nerve signals shared by the brain and digestive tract. At low doses, they may reduce amplified gut pain and help regulate bowel movement, so the prescription does not mean your symptoms are imagined or that you have depression.
Are antidepressants for IBS taken at lower doses than those used for depression?
Usually, doctors use much lower doses when these medicines are prescribed to change IBS-related nerve signaling; a tricyclic antidepressant may be started at a dose such as 10 mg daily. The exact dose and any changes should be determined by your prescriber.
Which antidepressant may help diarrhea-predominant IBS?
Tricyclic antidepressants, including amitriptyline, may help IBS pain and diarrhea-predominant IBS because they can slow digestion. They can also cause constipation, so your clinician should consider your usual bowel pattern before prescribing one.
Are SSRIs a standard treatment for IBS?
No. Major guidelines do not generally recommend selective serotonin reuptake inhibitors as a standard IBS treatment because evidence for reducing IBS pain is limited and inconsistent. They may be considered when depression or anxiety is also present, but they can cause nausea or diarrhea.
How long does it take for an antidepressant to help IBS?
Pain relief may take about 4 to 8 weeks because the medicine gradually changes nerve signaling. If it helps and is tolerated, treatment may continue for 6 to 12 months, with the duration individualized to your response.
What should I know about stopping or combining an IBS antidepressant?
Do not start, increase, combine, or stop the medicine without your prescriber’s guidance. Your doctor should review other prescriptions, over-the-counter medicines, and supplements for interactions and create an individualized taper to reduce discontinuation symptoms.
Which side effects from an IBS antidepressant need prompt medical attention?
Tricyclic antidepressants can cause dry mouth, blurred vision, trouble urinating, constipation, dizziness, or heart rhythm changes, while SSRIs can cause nausea, diarrhea, sleep changes, or sexual side effects. Seek prompt help for major mood or behavior changes, severe agitation, suicidal thoughts, fainting, or a severe allergic reaction.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is a low-dose neuromodulator a reasonable option for my specific type of IBS (diarrhea-predominant, constipation-predominant, or mixed)?
  2. 2.If we start a medication, what is the exact starting dose, and when will we reassess it?
  3. 3.What specific side effects should I watch out for, and which ones are reasons to call you urgently?
  4. 4.What benefit are we targeting—pain, diarrhea, sleep, or mood?
  5. 5.Will this medication interact with any of my other prescriptions or over-the-counter supplements?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome.

    Fadgyas Stanculete M, Dumitrascu DL, Drossman D

    Journal of gastrointestinal and liver diseases : JGLD 2021; (30(4)):517-525 doi:10.15403/jgld-4090.

    PMID: 34812436
  2. 2

    Post-Infectious Irritable Bowel Syndrome.

    Lee YY, Annamalai C, Rao SSC

    Current gastroenterology reports 2017; (19(11)):56 doi:10.1007/s11894-017-0595-4.

    PMID: 28948467
  3. 3

    Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.

    Kane JS, Ford AC

    Expert review of gastroenterology & hepatology 2016; (10(4)):431-42 doi:10.1586/17474124.2016.1140571.

    PMID: 26753693
  4. 4

    Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.

    Hanna-Jairala I, Drossman DA

    The American journal of gastroenterology 2024; (119(7)):1272-1284 doi:10.14309/ajg.0000000000002800.

    PMID: 38595149
  5. 5

    Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.

    Jin DC, Cao HL, Xu MQ, et al.

    World journal of gastroenterology 2016; (22(36)):8137-48 doi:10.3748/wjg.v22.i36.8137.

    PMID: 27688655
  6. 6

    Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.

    Wright-Hughes A, Ford AC, Alderson SL, et al.

    Health technology assessment (Winchester, England) 2024; (28(66)):1-161 doi:10.3310/BFCR7986.

    PMID: 39397570
  7. 7

    Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Ford AC, Wright-Hughes A, Alderson SL, et al.

    Lancet (London, England) 2023; (402(10414)):1773-1785 doi:10.1016/S0140-6736(23)01523-4.

    PMID: 37858323
  8. 8

    Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).

    Moayyedi P, Andrews CN, MacQueen G, et al.

    Journal of the Canadian Association of Gastroenterology 2019; (2(1)):6-29 doi:10.1093/jcag/gwy071.

    PMID: 31294724
  9. 9

    Journal of Clinical Gastroenterology Lectureship Dubai 2022 : Management of Irritable Bowel Syndrome With Diarrhea.

    Marasco G, Cremon C, Barbaro MR, et al.

    Journal of clinical gastroenterology 2024; (58(3)):221-231 doi:10.1097/MCG.0000000000001964.

    PMID: 38227850
  10. 10

    Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation.

    Jeong B, Sung TS, Jeon D, et al.

    Journal of cellular and molecular medicine 2022; (26(19)):4911-4923 doi:10.1111/jcmm.17348.

    PMID: 35560982
  11. 11

    Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome.

    Khan A, Menon R, Corning B, et al.

    Therapeutic advances in gastroenterology 2024; (18()):17562848241278125 doi:10.1177/17562848241278125.

    PMID: 39493642
  12. 12

    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.

    Chang L, Sultan S, Lembo A, et al.

    Gastroenterology 2022; (163(1)):118-136 doi:10.1053/j.gastro.2022.04.016.

    PMID: 35738724
  13. 13

    Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis.

    Khasawneh M, Mokhtare M, Moayyedi P, et al.

    The lancet. Gastroenterology & hepatology 2025; (10(6)):537-549 doi:10.1016/S2468-1253(25)00051-2.

    PMID: 40258375
  14. 14

    Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome.

    Lacy BE

    Alimentary pharmacology & therapeutics 2018; (48(8)):817-830 doi:10.1111/apt.14948.

    PMID: 30194692

This page explains why antidepressants may be used as low-dose neuromodulators for IBS and is for informational purposes only; it does not constitute medical advice. Discuss potential benefits, risks, dosing, and interactions with your prescriber.

Get notified when new evidence is published on irritable bowel syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.